Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick G Morris

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
NPJ Breast Cancer|September 27, 2023
Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancerNicola Cosgrove, Alex J Eustace, Peter O'Donovan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2020
A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor-Positive Breast CancerIan Krop, Vandana Abramson, Marco Colleoni, et al.
Cancers|April 3, 2021
Phase Ib Trial of Copanlisib, A Phosphoinositide-3 Kinase (PI3K) Inhibitor, with Trastuzumab in Advanced Pre-Treated HER2-Positive Breast Cancer "PantHER"Niamh M Keegan, Simon J Furney, Janice M Walshe, et al.
Journal of Translational Medicine|February 24, 2020
Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samplesSinead Toomey, Aoife Carr, Mateusz Janusz Mezynski, et al.
Cancers|July 10, 2020
Genomic and Transcriptomic Characterisation of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal CancerSinead Toomey, Jillian Gunther, Aoife Carr, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 18, 2018
A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast DiseaseAyca Gucalp, Xi K Zhou, Elise D Cook, et al.
Breast Cancer Research and Treatment|June 14, 2021
Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national studyLisa Prior, Richard O'Dwyer, Abdul Rehman Farooq, et al.
The Lancet. Oncology|January 18, 2021
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 studyErica L Mayer, Amylou C Dueck, Miguel Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 9, 2023
Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS TrialGeorg Pfeiler, Dominik Hlauschek, Erica L Mayer, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
NPJ Breast Cancer|September 27, 2023
Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancerNicola Cosgrove, Alex J Eustace, Peter O'Donovan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2020
A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor-Positive Breast CancerIan Krop, Vandana Abramson, Marco Colleoni, et al.
Cancers|April 3, 2021
Phase Ib Trial of Copanlisib, A Phosphoinositide-3 Kinase (PI3K) Inhibitor, with Trastuzumab in Advanced Pre-Treated HER2-Positive Breast Cancer "PantHER"Niamh M Keegan, Simon J Furney, Janice M Walshe, et al.
Journal of Translational Medicine|February 24, 2020
Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samplesSinead Toomey, Aoife Carr, Mateusz Janusz Mezynski, et al.
Cancers|July 10, 2020
Genomic and Transcriptomic Characterisation of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal CancerSinead Toomey, Jillian Gunther, Aoife Carr, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 18, 2018
A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast DiseaseAyca Gucalp, Xi K Zhou, Elise D Cook, et al.
Breast Cancer Research and Treatment|June 14, 2021
Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national studyLisa Prior, Richard O'Dwyer, Abdul Rehman Farooq, et al.
The Lancet. Oncology|January 18, 2021
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 studyErica L Mayer, Amylou C Dueck, Miguel Martin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 9, 2023
Impact of BMI in Patients With Early Hormone Receptor-Positive Breast Cancer Receiving Endocrine Therapy With or Without Palbociclib in the PALLAS TrialGeorg Pfeiler, Dominik Hlauschek, Erica L Mayer, et al.
Pageof 10